GPR37L1 and Duchenne muscular dystrophy: Further work may be focused on ERK phosphorylation and apoptosis in mdx mice, and the neuroprotective actions of PS and prosaptide mediated by GPR37 and GPR37L1 that may provide new therapeutic possibilities for the treatment of DMD.